Abstract
Approximately 40% of all insulin-dependent diabetic (IDDM) patients ultimately develop the clinical syndrome of diabetic nephropathy: persistent proteinuria associated with a decline in glomerular filtration rate (GFR) and elevated blood pressure [1–3]. This complication is the main cause of the increased morbidity and mortality in IDDM patients [4]. Renal failure due to nephropathy is the major cause of death (30%) in IDDM patients [2]. On average, death occurs 7 years after the start of persistent proteinuria. During the last decade, our knowledge with respect to prediction, development, progression, and treatment of diabetic nephropathy has increased tremendously. This chapter reviews renal function before and during antihypertensive treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Knowles HC: Magnitude of the renal failure problem in diabetes. Kidney Int 6: 2–7, 1974.
Deckert T, Poulsen JE, Larsen M: Prognosis of diabetics with diabetes onset before the age of thirty-one. I. Survival, causes of death and complications. Diabetologia 14: 363–370, 1978.
Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T: Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25: 496–501, 1983.
Borch-Johnsen K, Andersen PK, Deckert T: The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28: 590–596, 1985.
Shemesh O, Golbetz H, Kriss JP, Myers BD: Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int. 28: 830–838, 1985.
Viberti GC, Keen H, Mackintosh D: β2-Microglobulinaemia: a sensitive index of diminishing renal function in diabetics. Br Med J 282: 95–98, 1981.
Parving H-H, Andersen AR, Smidt UM: Monitoring progression of diabetic nephropathy. Ups J Med Sci 90: 15–23, 1985.
Parving H-H, Smidt UM, Friisberg B, Bonnevie-Nielsen V, Andersen AR: A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy. Diabetologia 20: 457–461, 1981.
Bröchner-Mortensen J: Current status on assessment and measurement of glomerular filtration rate. Clin Physiol 5: 1–17, 1985.
Parving H-H, Andersen AR, Hommel E, Smidt UM: The effect of antihypertensive treatment on diabetic nephropathy in insulin-dependent diabetic patients. In: Friedman EA, L’Esperance FA (eds) Diabetic renal-retinal syndrome. New York: Grune and Stratton, 1984, pp 183–190.
Mogensen CE: Progression of nephropathy in long-term diabetics with proteinuria and effect of initial anti-hypertensive treatment. Scand J Clin Lab Invest 36: 383–388, 1976.
Jones RH, Rayakawa H, Mackay JD, Parsons V, Watkins PJ: Progression of diabetic nephropathy. Lancet 1: 1105–1106, 1979.
Viberti GC, Bilous RW, Mackintosh D, Keen H: Monitoring glomerular function in diabetic nephropathy. Am J Med 74: 256–264, 1983.
Berglund J, Lins L-E, Lins P-E: Predictability in diabetic nephropathy. Acta Med Scand 215: 263–270, 1984.
Reubi FC, Franz KA, Horber F: Hypertension as related to renal function in diabetes mellitus. Hypertension [Suppl 2] 7: 21–28, 1985.
Watkins PJ, Blainey JD, Brewer DB, Fitzgerald MG, Malin JM, O’Sullivan DJ, Pinto JA: The natural history of diabetic renal disease. Q J Med 41: 437–456, 1972.
Mauer SM, Steffes MW, Ellis EM, Sutherland DER, Brown DM, Goetz FC: Structural—functional relationship in diabetic nephropathy. J Clin Invest 74: 1143–1155, 1984.
Osterby R, Andersen AR, Gregersen G, Gundersen HJG, Hommel E, Horlyck A, Jorgensen HE, Lokkegârd H, Mogensen CE, Nyberg G, Parving H-H, Svalander C: Quantitative structural data on the development of diabetic nephropathy. Diabetic Nephropathy 5: 10–11, 1986.
Berglund J, Lins L-E, Lins P-E: Metabolic and blood pressure monitoring in diabetic renal failure. Acta Med Scand 218: 401–408, 1985.
Hasslacher Ch, Stech W, Wahl P, Ritz E: Blood pressure and metabolic control as risk factors for nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia 28: 6–11, 1985.
Parving H-H, Andersen AR, Smidt UM, Oxenboll B, Edsberg B, Christiansen JS: Diabetic nephropathy and arterial hypertension. Diabetologia 24: 10–12, 1983.
Mogensen CE: Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J 285: 685–688, 1982.
Parving H-H, Andersen AR, Smidt UM, Svendsen PAa: Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet 1: 1175–1179, 1983.
Parving H-H, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PAa: Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J 294: 1443–1447, 1987.
Parving H-H, Andersen AR, Hommel-E, Smidt UM: Effects of long-term antihypertensive treatment on kidney function in diabetic nephropathy. Hypertension [Suppy 2] 7: 114–117, 1985.
Björck S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M: Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J 293: 471–474, 1986.
Hommel E, Parving H-H, Mathiesen E, Edsberg B, Nielsen MD, Giese J: Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. Br Med J 293: 467–470, 1986.
Hostetter TH, Rennke HG, Brenner BM: The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 72: 375–380, 1982.
Hostetter TH, Troy JL, Brenner BM: Glomerular hemodynamics in experimental diabetes. Kidney Int 19: 410–415, 1981.
Jensen PK, Christiansen JS, Steven K, Parving H-H: Renal function in streptozotocin diabetic rats. Diabetologia 21: 409–414, 1981.
Jensen PK, Steven K, Blæhr H, Christiansen JS, Parving H-H: Effects of indomethacin on glomerular hemodynamics in experimental diabetes. Kidney Int 29: 490–495, 1986.
Steffes MW, Brown DM, Mauer SM: Diabetic glomerulopathy following unilateral nephrectomy in the rat. Diabetes 27: 35–41, 1978.
Hostetter TH, Olsson JL, Rennke HG, Venkatachalam MA, Brenner BM: Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 241: 85–93, 1981.
Brenner BM: Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int 23: 647–655, 1983.
Steffes MW, Brown DM, Mauer SM: The development, enhancement, and reversal of the secondary complications of diabetes mellitus. Hum Pathol 10: 293–299, 1979.
Mauer SM, Steffes MW, Azar S, Sandberg SK, Brown DM: The effect of Goldblatt hypertension on development of the glomerular lesions of diabetes mellitus in the rat. Diabetes 27: 738–744, 1978.
Parving H-H, Viberti GC, Keen H, Christiansen JS, Lassen NA: Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism 32: 943–949, 1983.
Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77: 1925–1930, 1986.
Bank N, Klose R, Aynedjian HS: Glomerular pressure in rats with diabetes and hypertension [abstr]. Kidney Int 27: 41, 1985.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Parving, HH. (1988). The Course of Renal Function before and during Antihypertensive Treatment in Diabetic Nephropathy. In: Mogensen, C.E. (eds) The Kidney and Hypertension in Diabetes Mellitus. Topics in Renal Medicine, vol 6. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1974-1_23
Download citation
DOI: https://doi.org/10.1007/978-1-4757-1974-1_23
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-1976-5
Online ISBN: 978-1-4757-1974-1
eBook Packages: Springer Book Archive